Study to Find Out How Symptoms Severity Changes During the Standard Course of Treatment With the Cream Relief Pro and Suppositories Relief Pro (Active Ingredients Are Fluocortolone + Lidocaine) in Patients Suffering From Twisted and Bulging Veins in the Rectal Area (Acute Hemorrhoids)
Study to Find Out How Symptoms Severity Changes During the Standard Course of Treatment With the Cream Relief Pro and Suppositories Relief Pro (Active Ingredients Are Fluocortolone + Lidocaine) in Patients Suffering From Twisted and Bulging Veins in the Rectal Area (Acute Hemorrhoids)
In this study researcher wanted to learn more about the changes of biggest twisted and
 bulging veins in the rectal area (hemorrhoids) and changes of symptoms during a treatment
 period with the cream Relief Pro and suppositories Relief Pro. The study collected
 information on the treatment satisfaction of patients and their physicians with the
 prescribed treatment by using questionnaires. There were 3 visits at the physician's clinic
 for this study: one initial visit and 2 follow-up visits over a period of 2 weeks.
Inclusion Criteria:

 -  Male & female patients 18 to 65 years old;

 -  Patients with acute hemorrhoids 1 and 2 stage (with thrombosis (external, internal,
 mixed), including cases with bleeding);

 -  Prescription of fluocortolone + lidocaine as a part of routine clinical practice.

 Exclusion Criteria:

 -  Patients participating in an investigational program with interventions outside of
 routine clinical practice;

 -  Hemorrhoid with stage ˃ II;

 -  Contraindications for use of Relief PRO in the approved product label;

 -  Anemia and/or severe/profuse hemorrhoid bleeding;

 -  Surgery in perianal region in anamnesis;

 -  Concomitant treatment with antibiotics/antiseptics, antithrombotics, antineoplastic
 and/or immunosuppressant;

 -  Inflammatory bowel disease;

 -  Hepatic diseases in severe and acute stages;

 -  Colorectal cancer;

 -  Purulent-inflammatory diseases of the perianal region and anal canal;

 -  Chronic pulmonary diseases in severe and acute stages.